Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | BUB1 | O43683 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15392921 | 0.89 | NPSR1 (0.56) | NPSR1SMN1; SMN2HTTALDH1A1LMNA | |
| SCHEMBL13818128 | 0.84 | HTR2C (0.47) | ALDH1A1CYP2C19RAB9ANPC1DRD2 | |
| SCHEMBL17010980 | 0.83 | ALDH1A1 (0.41) | NPSR1SMN1; SMN2HTTALDH1A1LMNA | |
| SCHEMBL2540520 | 0.79 | BUB1 (0.49) | SMN1; SMN2HTTALDH1A1LMNAMAPT | |
| SCHEMBL2534029 | 0.77 | KIF11 (0.49) | SMN1; SMN2HTTALDH1A1LMNAPOLB | |
| SCHEMBL18002440 | 0.77 | KIF11 (0.49) | SMN1; SMN2ALDH1A1LMNAMAPTGAA | |
| SCHEMBL1009206 | 0.76 | NPSR1 (0.86) | NPSR1HTTALDH1A1MAPTCYP1A2 | |
| SCHEMBL29650380 | 0.76 | NPSR1 (0.86) | NPSR1HTTALDH1A1MAPTCYP1A2 | |
| SCHEMBL20546811 | 0.74 | ALDH1A1 (0.47) | SMN1; SMN2HTTALDH1A1LMNAMAPT | |
| SCHEMBL9158496 | 0.74 | NPSR1 (0.82) | NPSR1HTTALDH1A1MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107068914-B | Hole transport compositions and related devices and methods (I) | 日产化学工业株式会社 | 2020-05-08 | — | — | CN | disclosed |
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| EP-2588527-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | Plextronics, Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| WO-2012003485-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | OCIAD2, OCIAD1, SLCO1B1 | NPSR1 3206/4885SMN1; SMN2 3513/4885HTT 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.